RAMON LEE (MD) – Retina Specialist (Ophthalmology) Physician, NPI 1194119339
Retina Specialist (Ophthalmology) Physician
Main info
Doctor Profile
Contacts
Profile Insights
NPPES metrics only — not quality of care.
844 OPHTHALMOLOGY in MI
Provider Addresses for RAMON LEE (MD)
19550 GOVERNORS HWY STE 3600
FLOSSMOOR, IL 604222147
Phone: (708) 647-9211
Fax: (708) 647-9333
Type: Mailing
39650 ORCHARD HILL PL STE 200
NOVI, MI 483755391
Phone: (248) 319-0161
Fax: (248) 319-0170
Type: Mailing
3555 W 13 MILE RD STE LL-20
ROYAL OAK, MI 480736710
Phone: (248) 288-2280
Fax: (248) 288-5644
Type: Location
10110 Donald S Powers Dr Ste 101A
Munster, IN 463214071
Phone: (219) 922-9888
Fax: (219) 922-9088
Type: Location
16055 108th Ave Ste E
Orland Park, IL 604675347
Phone: (708) 364-3240
Fax: (708) 364-7252
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 55 Open Payments records for all available years, with a total value of $13,430.
Total Amount is formed as General ($13,430) + Research ($0) + Ownership ($0) = $13,430.
Last reported payment date: 2024-12-12 • Largest payer in this snapshot: Regeneron Pharmaceuticals, Inc. ($8,322).
Total Amount
$13,430
General + Research + Ownership
Payments
55
Total payment records
General Amount
$13,430
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-12
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Regeneron Pharmaceuticals, Inc. | $8,322 |
| Bausch & Lomb Americas Inc. | $2,000 |
| Alimera Sciences, Inc. | $1,370 |
| Astellas Pharma US Inc | $412 |
| Apellis Pharmaceuticals, Inc. | $152 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2021-07-19
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking 2 Medicare enrollment records; no due dates published yet.
Enrollment records
2
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20210715002021 | I | Ophthalmology | IN | TBD |
| I20210719002941 | I | Ophthalmology | IL | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 26,700 | 95 | $0 |
| 92134 | Imaging of retina | 4,668 | 1,619 | $0 |
| J0178 | Injection, aflibercept, 1 mg | 2,816 | 278 | $0 |
| 67028 | Injection of drug into eye | 2,561 | 488 | $0 |
| J2778 | Injection, ranibizumab, 0.1 mg | 2,289 | 135 | $0 |
Insurance plans in this area (ZIP 60422)
Loading plans...
Group practice members
| Name | Specialty | State |
|---|---|---|
| O P H T H A L M O L O G Y | IL | |
| O P H T H A L M O L O G Y | IL | |
| O P H T H A L M O L O G Y | IL | |
| O P H T H A L M O L O G Y | IL | |
| O P H T H A L M O L O G Y | IL | |
| O P H T H A L M O L O G Y | MI | |
| O P H T H A L M O L O G Y | IL | |
| O P H T H A L M O L O G Y | IL | |
| - | IL | |
| - | IL |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.